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Objective/background: Nontuberculous mycobacteria (NTM) are not known to be associated
with fistula-in-ano. NTM was detected in three fistula-in-ano patients in our series. In this
study, related data was reviewed to find the mycobacterial disease in patients in our data-
base. Methods: In this study, 311 consecutive fistula-in-ano patients operated over 2 years
were analyzed. The histopathology of anal fistula tract epithelial lining of every operated
patient was analyzed and other tests (real-time-polymerase chain reaction [RT-PCR], Gen-
eXpert, and mycobacterial culture) were conducted in patients with high index of suspicion
of having mycobacterial disease. Results: Two patients had histopathological features sug-
gestive of mycobacterial disease. Of these, one patient had NTM and the other had
Mycobacterium tuberculosis (MTB) on RT-PCR. Four patients had normal histopathology
features but tested positive on RT-PCR (2 each for NTM and MTB). Therefore, a total of
six patients were tested for mycobacterial disease (3 each for NTM and MTB).
Mycobacterium culture was performed in two patients (both NTM) but the result was neg-
ative. Five of six patients (NTM = 2, MTB = 3) presented with delayed recurrences after oper-
ation (6–18 months after complete healing). Conclusion: NTM can cause fistula-in-ano. It
could be an undiagnosed contributory factor in fistula recurrence. Mycobacterial disease
(both tuberculous and nontuberculous) may be associated with delayed recurrence of
fistula. RT-PCR is highly sensitive and can differentiate between NTM and MTB. It should
perhaps be performed in all recurrent and refractory cases.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Although Mycobacterium tuberculosis (MTB) infection is consid-
ered to be a diminishing clinical problem in industrializedcountries, it continues to be a dominant public health
concern in many developing ones [1]. However, the incidence
of nontuberculous mycobacteria (NTM) infections has
increased in developed countries with the global human
Fig. 2 – Langhans giant cell in a 37-year-old male patient
with recurrent fistula-in-ano with nontuberculous
mycobacteria on real-time-polymerase chain reaction.
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drome epidemic and the use of immunosuppressive agents
[1]. Unlike MTB, which is transmitted from one person to
another, NTM are abundant in nature, soil, and water, and
are believed to be acquired by environmental exposure.
Different species of NTM prefer different environmental con-
ditions, and thus, they are also known as environmental
bacteria.
Extrapulmonary TB is responsible for 3–46% of all types of
TB cases worldwide [2]. Of these, perianal TB is a rare type
accounting for only 0.7% of these cases [3]. However, it is very
likely that the prevalence of perianal TB is underestimated as
it remains undiagnosed or gets misdiagnosed as Crohn’s dis-
ease or other granulomatous diseases [4]. NTM is not known
to be associated with perianal or fistula-in-ano disease.
NTM was detected in three fistula-in-ano patients in our
series. The data were reviewed to find the mycobacterial
disease in patients in our database.
Materials and methods
A retrospective analysis of 311 consecutive fistula-in-ano
patients operated in a referral fistula center between August
2013 and October 2015 was performed.
The protocol of our center was to send the histopathology
of anal fistula tract epithelial lining of every operated patient
for further analysis. Because NTM was not known to be asso-
ciated with fistula-in-ano, patients with histopathological
features suggestive of mycobacterial disease (granuloma for-
mation, caseation necrosis, epithelioid cells, or Langhans
giant cells; Figs. 1 and 2) were assumed to be suffering from
MTB and standard antitubercular therapy was started in
these patients. This practice was continued until NTM was
detected on real-time-polymerase chain reaction (RT-PCR).
Since then, RT-PCR was performed in cases in which
mycobacterial disease was suspected clinically. However, it
was not performed in all operated fistula cases due to cost
constraints. RT-PCR is highly sensitive and can differentiate
between TB and NTM but has low specificity (due to falseFig. 1 – Epithelioid cell granuloma with early cessation
necrosis in a 37-year-old male patient with recurrent fistula-
in-ano with nontuberculous mycobacteria on real-time-
polymerase chain reaction.positives and contamination) [5]. By contrast, both
histopathological analysis and mycobacterial culture have
low yield [6,7]. Therefore, RT-PCR positivity and the overall
clinical picture were correlated to arrive at a diagnosis. Other
related tests (chest X-ray, Mantoux test, GeneXpert, Mycobac-
terium culture) were performed as deemed necessary.
Delayed recurrence of fistula-in-ano was defined when a
patient with fistula-in-ano was completely cured after the
fistula surgery but had a recurrence 6–18 months after the
operation.
Results
Histopathology of anal fistula tract epithelium was analyzed
in 311 fistula-in-ano patients and only two patients had fea-
tures suggestive of mycobacterial disease. Of these, one
patient had NTM and the other had MTB on RT-PCR. A total
of six patients were tested for mycobacterial disease (3 each
for NTM and MTB) on RT-PCR (Table 1). Four (2 each for
NTM and MTB) of these six patients had normal histopathol-
ogy features. Mycobacterium culture was done in two patients
(NTM positive on RT-PCR) but the result was negative. Five of
the six patients (NTM = 2, MTB = 3) presented with delayed
recurrences after the operation (6–18 months after complete
healing; Table 1). All patients diagnosed with NTM received
an oral antibiotic combination (clarithromycin + sulfona
mides/faropenem/doxycycline), which empirically covered
all common skin and soft-tissue infections causing NTM
(Mycobacterium fortuitum group, Mycobacterium abscessus,
Mycobacterium chelonae, and Mycobacterium marinum) [8]. The
two-drug combination was given for 3 months and all the
patients responded well with complete healing of their
fistula.
The study clearly indicated that histopathology had lower
sensitivity as compared with RT-PCR. It would have been
interesting to compare the sensitivity of histopathology and
RT-PCR. As we know, the sensitivity of a test is the probability
that a test will indicate disease among those with the disease.
Because there is no gold standard test to diagnose
Table 1 – Details of patients with nontuberculous mycobacteria and Mycobacterium tuberculosis.
Patient Histopathology (anal
fistula tract lining)
Real-time-polymerase
chain reaction
Culture Delayed recurrence
after operation
Response to
standard
antitubercular
therapy
Response to
empirical
NTM therapy
(clarithromycin
+ sulfonamides)
1 Positive NTM Negative Yes Not given Successful
2 Negative NTM Negative Yes Given but failed Successful
3 Negative NTM Not done No Not given Successful
4 Positive MTB Not done Yes Successful Not applicable
5 Negative MTB Not done Yes Successful Not applicable
6 Negative MTB Not done Yes Successful Not applicable
Note: The empirical therapy of NTM given was clarithromycin + sulfonamides/faropenem/doxycycline. This was done because the common
NTM species that cause extrapulmonary abscesses and soft-tissue infections (Mycobacterium fortuitum group, Mycobacterium abscessus,
Mycobacterium chelonae, and Mycobacterium marinum) are responsive to these antibiotics. MTB =Mycobacterium tuberculosis; NTM = nontuber-
culous mycobacteria.
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patients with fistula-in-ano in this study were actually suffer-
ing from the mycobacterial disease. In the absence of knowl-
edge of total number of patients suffering frommycobacterial
disease, it was not possible to calculate the sensitivity of
either of the tests (histopathology and RT-PCR). Second, RT-
PCR was not performed in all patients, but only in patients
with high index of suspicion. This would have led to a signif-
icant sampling bias if these data were used to calculate
sensitivity. The only parameter that can be calculated is
prevalence of mycobacterial disease on histopathology
(2/317 = 0.63%). This cannot be calculated for RT-PCR due to
sampling bias.
Discussion
This is a first time that NTM have been shown to be associ-
ated with fistula-in-ano. This finding has a number of impor-
tant implications.
The diagnosis of mycobacterial disease is not easy and
straightforward. Most of the mycobacterial bacilli are slow
growing and ubiquitous. This leads to difficulty in culturing
these microorganisms and problem of contamination.
Although a number of tests are available, the interpretation
of their results is not simple. Ziehl-Neelsen carbol-fuchsin
staining for acid-fast bacillus and histopathological features
can neither differentiate between MTB and NTM [6] nor
between different species of NTM [6,7]. Some recent studies
have outlined characteristics to differentiate MTB from NTM
(neutrophil infiltration, interstitial granuloma, small vessel
proliferation, and increased numbers of bacilli were found
to be associated more with NTM, whereas giant cells, plasma
cells, tuberculoid granulomas, and necrosis were associated
more with TB) [6]; however, these need to be confirmed in
more studies before they can be routinely used.
Mycobacterial culture is more specific and sensitive than
histopathology but requires weeks of incubation and cannot
differentiate between infection and contamination. PCR is
now routinely available, but requires careful control to pre-
vent contamination and false-positive results [9]. RT-PCR
can differentiate between TB and NTM [5] but it cannot differ-
entiate between different species of NTM. Gene sequenceanalysis (PCR-amplified hypervariable regions of the 16S ribo-
somal RNA gene) can differentiate between species of NTM
[10–12] but it is quite costly and will not help to know about
antibiotic sensitivity. GeneXpert (Xpert MTB/RIF) is an auto-
mated, heminested RT-PCR that not only detects TB but also
tests for rifampicin sensitivity using molecular beacons [13].
It is also rapid as the result can be obtained within 2 h. How-
ever, it cannot differentiate between TB and NTM.
NTM is not known to be a causative agent in fistula-in-ano.
The findings of this study bring to light a new factor that
could be responsible for fistula causation or recurrence. At
the same time, it raises several questions and adds to the
dilemma of treating fistula-in-ano.
1. NTM could be responsible for repeated recurrences (refrac-
toriness to treatment) in some proportion of fistula-in-ano
cases.
2. Up to now, histopathology was the test routinely done to
detect MTB in fistula-in-ano. The findings of this study
reaffirm that histopathology has low sensitivity and per-
haps misses a significant proportion of mycobacterial
cases.
3. Mycobacterial disease on histopathology of anal fistula
(granuloma, caseation necrosis, epithelioid cells, and
Langhans giant cells) was routinely diagnosed as MTB
and treated by standard antitubercular therapy. NTM gives
a similar picture on histopathology as TB (Figs. 1 and 2).
Therefore, the histopathological features of mycobacterial
disease cannot be diagnosed as TB and should be evalu-
ated further to ascertain whether they are because of TB
or NTM.
4. Histopathology cannot differentiate between TB and NTM
and the yield of histopathology is lower than RT-PCR. This
raises the following question: ‘‘Should RT-PCR be per-
formed in all biopsy samples of fistula-in-ano patients or
in only those with histopathology suggestive of mycobac-
terial disease?”
5. RT-PCR cannot give details about different species of NTM.
Only mycobacterial culture can differentiate between spe-
cies of NTM and can help to determine their antibiotic sen-
sitivity. However, the culture takes a long time (4–6 weeks)
and has low yield. Different species of NTM have different
Table 2 – Common NTM species that cause extrapulmonary abscesses and soft-tissue infections and their antibiotic
sensitivity.
Species of NTM First line Second line Second line Second line
Mycobacterium fortuitum Clarithromycin Sulfonamides
(trimethoprim–sulfamethoxazole)
Amikacin Imipenem, cefoxitin,
ciprofloxacin, & doxycycline
Mycobacterium abscessus Clarithromycin Amikacin Imipenem & cefoxitin
Mycobacterium chelonae Clarithromycin Amikacin Imipenem & tobramycin
Mycobacterium marinum Clarithromycin Sulfonamides
(trimethoprim–sulfamethoxazole)
Doxycycline, rifampin,
ethambutol, & minocycline
Note: NTM = nontuberculous mycobacteria.
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antitubercular therapy, whereas others respond to differ-
ent conventional antibiotics). In such a scenario and in
the paucity of any data or guidelines in the literature as
to which species of NTM cause fistula-in-ano, any treat-
ment (even empirical) is difficult to start.
In this study, empirical treatment was started in patients
diagnosed with NTM infection (diagnosis made on RT-PCR
along with clinical picture). In the absence of any guidelines
in the literature, simple scientific strategy was followed. The
literature was analyzed to tabulate the most common NTM-
causing skin and soft-tissue infections and their known
antibiotic sensitivity (Table 2) [8]. The oral antibiotic combina-
tion (clarithromycin + sulfonamides/faropenem/doxycycline),
which covered all these NTM (M. fortuitum group,M. abscessus,
M. chelonae, and M. marinum), was selected [8]. The two-drug
combination was recommended for 3 months. Probiotics
were also recommended along with these.
Delayed recurrence (recurrence of fistula 6–18 months
after complete healing of fistula) was observed in 83.3% (5/6)
of patients who tested positive for mycobacterial diseases
on RT-PCR. A possible explanation for this could be that most
of the Mycobacteria are slow growers and take a few weeks to
months to multiply. Usually, a fistula heals after operation
within 6–10 weeks. This duration is too short for Mycobacteria
to multiply to substantial numbers. Therefore, presence of
Mycobacteria perhaps does not stop fistula from healing but
causes delayed abscess formation and recurrence after few
months once they get sufficient time to multiply and grow.
To conclude, both NTM and TB can cause fistula-in-ano.
They should be especially suspected in patients having
a delayed recurrence (recurrence after 6–18 months).
Histopathology alone cannot be relied upon to detect
mycobacterial disease. RT-PCR should be done in patients
with high index of suspicion for mycobacterial disease. More
data need to be accumulated across the world and guidelines
about how to approach (diagnose and treat) mycobacterial
disease (TB and NTM) in fistula-in-ano cases should be
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